Alizapride

Alizapride
	File:Alizapride.svg
Clinical data
Routes of; administration	Oral, intramuscular, intravenous
ATC code	A03FA05 (WHO) ;
Pharmacokinetic data
Elimination half-life	3 hours
Excretion	Renal
Identifiers
	IUPAC name N-[(1-allylpyrrolidin-2-yl)methyl]-6-methoxy-; 1H-benzotriazole-5-carboxamide;
CAS Number	59338-93-1;
PubChem CID	43008;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C16H21N5O2
Molar mass	315.37 g/mol

Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide.^[1]

Alizapride is marketed under various trade names including Plitican, Superan and Vergentan.^[2]

References

↑ Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M (1988). "Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial". Cancer Chemother Pharmacol. 22 (4): 316–20. PMID 3048762.
↑ Template:Fr icon "Alizapride Chlorhydrate". BIAM. June 2 1997. Retrieved 2007-08-14. Check date values in: |date= (help)

Clinical data
File:Alizapride.svg
Routes of administration	Oral, intramuscular, intravenous
ATC code	A03FA05 (WHO)
Pharmacokinetic data
Elimination half-life	3 hours
Excretion	Renal
Identifiers
IUPAC name N-[(1-allylpyrrolidin-2-yl)methyl]-6-methoxy- 1H-benzotriazole-5-carboxamide
CAS Number	59338-93-1
PubChem CID	43008
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₆H₂₁N₅O₂
Molar mass	315.37 g/mol